WHO Drug Information Vol. 23, No. 1, 2009 - World Health ...

More documents

Recommendations

Info

WHO Drug Information, Vol. 23, No. 1, 2009 Recommended INN: List 61intiquinatinumintiquinatineintiquinatineintiquinatina(2R)-2-{4-[(7-bromoquinolin-2-yl)oxy]phenoxy}propanoic acidacide (2R)-2-{4-[(7-bromoquinoléin-2-yl)oxy]phénoxy}propanoïqueácido (2R)-2-{4-[(7-bromoquinolin-2-il)oxi]fenoxi}propanoicoC 18 H 14 BrNO 4BrNOHCH 3OCO 2 Hlancovutidumlancovutidelancovutidelancovutida(C 3,15 R)-C 3,15 -hydroxy[2-L-lysine,10-L-phenylalanine,12-L-phenylalanine-,13-L-valine]lantibiotic ancovenin (Streptomycessp)(C 3,15 R)-C 3,15 -hydroxy[2-L-lysine,10-L-phénylalanine,12-L-phénylalanine-,13-L-valine]ancovénine antibiotique(Streptomyces sp)C 3,15 R)-C 3,15 -hidroxi[2-L-lisina,10-L-fenilalanina,12-L-fenilalanina-,13-L-valina]ancovenina antibiótico (Streptomyces sp)C 89 H 125 N 23 O 25 S 3H 2NHLys Gln NHOHONHHOHNHOSSSPhe Gly Pro Phe NHCH 3HPhe Val NHOHOHO 2CNHHOOHHGly Asn NHOHNHCO 2HHNCH 3Hlarazotidumlarazotidelarazotidelarazotidaglycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycineglycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycineglicilglicil-L-valil-L-leucil-L-valil-L-glutaminil-L-prolilglicinaC 32 H 55 N 9 O 10H Gly Gly Val Leu Val Gln Pro Gly OHlensiprazinumlensiprazinelensiprazinelensiprazina(2R)-8-{4-[3-(5-fluoro-1H-indol-3-yl)propyl]piperidin-1-yl}-2-methyl-2H-1,4-benzooxazin-3(4H)-one(-)-(2R)-8-{4-[3-(5-fluoro-1H-indol-3-yl)propyl]pipérazin-1-yl}-2-méthyl-2H-1,4-benzoxazin-3(4H)-one(2R)-8-{4-[3-(5-fluoro-1H-indol-3-il)propil]piperidin-1-il}-2-metil-2H-1,4-benzooxazin-3(4H)-ona65
Recommended INN: List 61 WHO Drug Information, Vol. 23, No. 1, 2009C 24 H 27 FN 4 O 2FOHNONNNHH CH 3levomilnacipranumlevomilnacipranlévomilnacipranlevomilnaciprán(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide(-)-(1S,2R)-2-(aminométhyl)-N,N-diéthyl-1-phénylcyclopropanecarboxamide(-)-(1S,2R)-2-(aminometil)-N,N-dietil-1-fenilciclopropanocarboxamidaC 15 H 22 N 2 OCH 3O N CH 3HNH 2linagliptinumlinagliptinlinagliptinelinagliptina8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione8-[(3R)-3-aminopipéridin-1-yl]-7-(but-2-yn-1-yl)-3-méthyl-1-[(4-méthylquinazolin-2-yl)méthyl]-3,7-dihydro-1H-purine-2,6-dione8-[(3R)-3-aminopiperidin-1-il]-7-(but-2-in-1-il)-3-metil-1-[(4-metilquinazolin-2-il)metil]-3,7-dihidro-1H-purina-2,6-dionaC 25 H 28 N 8 O 2NNONONNNNCH 3HNH 2CH 3CH 3lixisenatidumlixisenatidelixisénatidelixisenatidades-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamidedés-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamidedes-38-prolina-exendina-4 (Heloderma suspectum)-(1-39)-peptidilpenta-L-lisil-L-lisinamida66
Page 2 and 3:
WHO Drug Information Vol 23, No. 1,
Page 4 and 5:
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17: WHO Drug Information Vol 23, No. 1,
Page 50 and 51: WHO Drug Information, Vol. 23, No.
Page 84: WHO Drug Information, Vol. 23, No.
show all

WHO Drug Information Vol. 23, No. 1, 2009 - World Health ...

Create successful ePaper yourself

Delete template?

Save as template?